Standard BioTools to Cut 15% of Workforce Amid Restructuring

Dow Jones

Sep 18, 2025

By Katherine Hamilton

Standard BioTools plans to cut 15% of its global staff as part of a restructuring plan.

The provider of life-science tools is reducing its workforce to improve operational efficiency and lower operating costs in line with current revenue projections, it said in a filing Wednesday.

Expenses related to the job cuts are expected to be about $7.5 million. Those costs should be payable over the next several months, Standard BioTools said.

The San Francisco company is anticipating lower revenue because of funding pressures at the National Institutes of Health, it said in its last three financial reports. It expects the decline in its Americas academic revenue to decline by high single-digit millions.

Standard BioTools last quarter also announced the sale of SomaLogic, which is planned to close in the first half of 2026. The company said in August it expects revenue from continuing operations to be $78 million to $83 million for the full year, whereas combined revenue was projected to be $165 million to $175 million.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

September 17, 2025 16:59 ET (20:59 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2568412732"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2568412732\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2568412732?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-18 04:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2568412732","market":"other","top_or_hot":-1,"title":"Standard BioTools to Cut 15% of Workforce Amid Restructuring","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Katherine Hamilton \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/LAB\">Standard BioTools</a> plans to cut 15% of its global staff as part of a restructuring plan. \n</p>\n<p>\n  The provider of life-science tools is reducing its workforce to improve operational efficiency and lower operating costs in line with current revenue projections, it said in a filing Wednesday. \n</p>\n<p>\n  Expenses related to the job cuts are expected to be about $7.5 million. Those costs should be payable over the next several months, Standard BioTools said. \n</p>\n<p>\n  The San Francisco company is anticipating lower revenue because of funding pressures at the National Institutes of Health, it said in its last three financial reports. It expects the decline in its Americas academic revenue to decline by high single-digit millions. \n</p>\n<p>\n  Standard BioTools last quarter also announced the sale of SomaLogic, which is planned to close in the first half of 2026. The company said in August it expects revenue from continuing operations to be $78 million to $83 million for the full year, whereas combined revenue was projected to be $165 million to $175 million. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 17, 2025 16:59 ET (20:59 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Standard BioTools to Cut 15% of Workforce Amid Restructuring</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStandard BioTools to Cut 15% of Workforce Amid Restructuring\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-09-18 04:59</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Katherine Hamilton \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/LAB\">Standard BioTools</a> plans to cut 15% of its global staff as part of a restructuring plan. \n</p>\n<p>\n  The provider of life-science tools is reducing its workforce to improve operational efficiency and lower operating costs in line with current revenue projections, it said in a filing Wednesday. \n</p>\n<p>\n  Expenses related to the job cuts are expected to be about $7.5 million. Those costs should be payable over the next several months, Standard BioTools said. \n</p>\n<p>\n  The San Francisco company is anticipating lower revenue because of funding pressures at the National Institutes of Health, it said in its last three financial reports. It expects the decline in its Americas academic revenue to decline by high single-digit millions. \n</p>\n<p>\n  Standard BioTools last quarter also announced the sale of SomaLogic, which is planned to close in the first half of 2026. The company said in August it expects revenue from continuing operations to be $78 million to $83 million for the full year, whereas combined revenue was projected to be $165 million to $175 million. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 17, 2025 16:59 ET (20:59 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SMP","symbol_name":"Standard Motor Products Inc","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2568412732","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2568412732","pubTimestamp":1758142740,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Standard BioTools plans to cut 15% of its global staff as part of a restructuring plan.The provider of life-science tools is reducing its workforce to improve operational efficiency and lower operating costs in line with current revenue projections, it said in a filing Wednesday.Expenses related to the job cuts are expected to be about $7.5 million. Those costs should be payable over the next several months, Standard BioTools said.The San Francisco company is anticipating lower revenue because of funding pressures at the National Institutes of Health, it said in its last three financial reports. It expects the decline in its Americas academic revenue to decline by high single-digit millions.Standard BioTools last quarter also announced the sale of SomaLogic, which is planned to close in the first half of 2026. The company said in August it expects revenue from continuing operations to be $78 million to $83 million for the full year, whereas combined revenue was projected to be $165 mil","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SMP":"Standard Motor Products Inc","BK4121":"生命科学工具和服务","BK4124":"机动车零配件与设备","LAB":"Standard BioTools Inc."},"translate_title":"Standard BioTools将在重组中裁员15%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LAB":0.9,"SMP":1.5},"content_text":"By Katherine Hamilton \n\n\n \n\n\nStandard BioTools plans to cut 15% of its global staff as part of a restructuring plan. \n\n\n  The provider of life-science tools is reducing its workforce to improve operational efficiency and lower operating costs in line with current revenue projections, it said in a filing Wednesday. \n\n\n  Expenses related to the job cuts are expected to be about $7.5 million. Those costs should be payable over the next several months, Standard BioTools said. \n\n\n  The San Francisco company is anticipating lower revenue because of funding pressures at the National Institutes of Health, it said in its last three financial reports. It expects the decline in its Americas academic revenue to decline by high single-digit millions. \n\n\n  Standard BioTools last quarter also announced the sale of SomaLogic, which is planned to close in the first half of 2026. The company said in August it expects revenue from continuing operations to be $78 million to $83 million for the full year, whereas combined revenue was projected to be $165 million to $175 million. \n\n\n \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 17, 2025 16:59 ET (20:59 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}